BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
82.66
-1.43 (-1.70%)
At close: Jul 15, 2026, 4:00 PM EDT
82.66
0.00 (0.00%)
After-hours: Jul 15, 2026, 4:10 PM EDT

BridgeBio Pharma Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$110$120
BuyReiterates$110$120+45.17%Jul 13, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$101
BuyMaintains$101+22.19%Jul 9, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$111
BuyMaintains$111+34.29%Jul 9, 2026
Barclays
Barclays
Buy
Reiterates
$157
BuyReiterates$157+89.93%Jul 8, 2026
RBC Capital
RBC Capital
Buy
Maintains
$100
BuyMaintains$100+20.98%Jul 7, 2026
Jefferies
Jefferies
Buy
Maintains
$100
BuyMaintains$100+20.98%Jul 6, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$96
BuyMaintains$96+16.14%Jun 22, 2026
Raymond James
Raymond James
Buy
Maintains
$125$98
BuyMaintains$125$98+18.56%Jun 17, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.